NCT07032428Not yet recruiting
Efficacy of kTMP, a Novel Non-invasive Brain Stimulation Method, for the Treatment of Anhedonia
Source: ClinicalTrials.gov · Last updated 8 Jul 2026
Brief summary (registry, in English)
The goal of this proposal is to provide a first assessment of the efficacy of our innovative non-invasive brain stimulation system, kTMP, in the treatment of anhedonia in MDD.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 104 (estimated)
- First submitted
- 14 Jun 2025
- Start date
- 15 Jul 2026
- Primary completion date
- 30 Jul 2028
- Lead sponsor
- Magnetic Tides
- Diseases
- Depression
- NCT number
- NCT07032428
What you commit to
- Study type: Interventional
- Planned participants: 104
- From 15 Jul 2026 to the primary completion date, 30 Jul 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age in the registry: 21 years to 80 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.